Skip to main content
. 2021 Nov 18;118(47):e2112674118. doi: 10.1073/pnas.2112674118

Fig. 6.

Fig. 6.

Schematic diagram of the CDK5–FBXO22–PD-L1 pathway. Inhibition of CDK5 increases the expression of the ubiquitin ligase FBXO22, which in turn decreases PD-L1 levels by ubiquitination. Degradation of PD-L1 increases sensitivity to chemotherapy or radiation.